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ABSTRACT
Objective: To assess proliferative diabetic retinopathy (PDR) and to describe the difference in angiographic
representation of new vessels (NVs) and Intra retinal microvascular abnormalities (IRMA) on optical
coherence tomography angiography (OCTA).
Methods: A cross-sectional observational study was performed at ISRA Postgraduate Institute of
Ophthalmology, Karachi, from March 2018 to September 2018. Forty-two eyes of 21 patients with history of
diabetes mellitus (DM) were examined. Twenty-eight eyes with a clinical diagnosis of severe non proliferative
diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR) according to early treatment diabetic
retinopathy study (ETDRS) were included and evaluated using Swept source optical coherence tomography
angiography (SS-OCTA). Then face wide ﬁeld SS-OCTA images and co registered structural optical coherence
tomography (OCT) with ﬂow overlay were used to distinguish the features of IRMA and retinal NVs.
Results: Forty-two eyes (21 patients) were examined clinically. Fourteen eyes had moderate NPDR, 15 had
severe NPDR and 13 eyes had changes consistent with PDR. After clinical diagnosis, we included 28 eyes in
our study based on inclusion criteria. These 28 eyes went through SS-OCTA evaluation and we observed 15
cases with PDR and 13 with severe NPDR changes. The OCTA and clinical diagnosis were similar except in 2
eyes, which is critical but not statically significant showing the importance of this noninvasive technology.
Conclusions: Widefield OCTA can work as an alternative to fundus fluorescein angiography (FFA) in the
diagnosis of diabetic retinopathy (DR). As it is a non-invasive and depth encoded technique so can be used
frequently to monitor the retinal changes and their progression.
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Diabetic retinopathy (DR) is one of the leading
complications of diabetes mellitus (DM) with the
treatment philosophy based on the severity of the
retinal changes. There are approximately 93 million people with DR worldwide, out of which 17
million have proliferative diabetic retinopathy
(PDR).1 The National Survey of blindness conducted in Pakistan in 2007 estimated that there were at
least 90,000 to 100,000 adults with vision threatening diabetic retinopathy (VTDR) requiring eye
care.2 The prevalence of DR is expected to increase
due to the use of more sensitive detection tools
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such as optical coherence tomography (OCT), optical coherence tomography angiography (OCTA),
ultra-wide fundus photography and angiography.
DR is classified into non proliferative and proliferative stages. The non-proliferative diabetic retinopathy (NPDR) manifests microvascular changes,
including micro aneurysms, intra retinal hemorrhages, venous beading and intra retinal microvascular abnormalities (IRMA), whereas proliferative
diabetic retinopathy (PDR) is identified by retinal
neovascularization (NV) that develops in response
to retinal ischemia. NVs are bunch of fine vessels
lying on the surface of the retina, while Intra retinal
microvascular abnormalities (IRMA) are deﬁned as
collateral vessels arising from the preexisting capillaries and are located entirely within the retina and
are difficult to distinguish from early extra retinal neovascularization. Early detection of severe
NPDR and early PDR is very important in DR treatment as the chance of progression to vision threatening diabetic retinopathy (VTDR) within one year
is calculated at 50 percent.3 Optical coherence tomography (OCT) is a non-invasive technique and
has gained popularity over the last two decades for
acquiring cross sectional retinal images. It is based
on the principle of optical reflectometry, which involves the measurement of light back-scattering
through transparent or semi-transparent media
such as retina.4 It is useful for the diagnosis and
monitoring of DR, especially diabetic macular edema (DME). However, we cannot visualize new vessels with structural OCT scans.5,6 To overcome this
limitation, OCTA has gained popularity to map out
retinal and choroidal vasculature. It is a non-invasive, rapid, depth encoded technique and is without the use of fluorescein dye. Then face OCTA can
easily visualize the vascular structure of retina and
choroid and is ideal noninvasive tool for diagnosis,
management and monitoring of different stages of
DR, Age related macular degeneration (ARMD)
and other chorioretinal vascular disorders.7,8
It is important to diagnose and distinguish
severe NPDR and PDR and treat it early to prevent
vision loss from nonvascular complications so
en face OCTA with structural OCT is a useful
technique to distinguish between NVs and IRMAs.
The aim of this study was to differentiate NVs and
IRMAs with this noninvasive technique in patients
with diabetic retinopathy.

Ophthalmology, Karachi, from March 2018 to
September 2018. Forty-two eyes of 21 patients
with history of DM were examined. Twenty-eight
eyes with a clinical diagnosis of severe NPDR
or PDR according to early treatment diabetic
retinopathy study (ETDRS) were included.9 The
study approval was granted by Institute’s Ethical
Committee on 18th January 2018 with protocol
number A-00044/A and was carried out according
to the declaration of Helsinki.
All patients provided informed consent
to participate in this study and underwent
comprehensive
ophthalmologic
examination,
including measurement of the best-corrected
visual acuity (BCVA), intraocular pressure (IOP),
slit-lamp bio microscopy and fundus examination
with 90 diopter lens. All included cases of PDR
and severe NPDR were evaluated with SS OCTA
(Topcon DRI OCT Triton, Japan). This device has
an image acquisition speed of 100,000 A-scans per
second, an axial resolution of 8µm, and transverse
resolution of 20 µm. The swept-source OCT has a
longer wavelength at 1,050 nm with less signal
roll off at increased imaging depth compared
with spectral domain OCT20-26. This device has
both conventional OCT, en face OCT and OCTA
capability. The enface wideﬁeld SS-OCTA images
and the co registered structural OCT with ﬂow
overlay were used to distinguish the features of
IRMAs and retinal NVs. The term ﬂow overlay
means ﬂow on the cross-sectional OCT images5.The
12/12 mm SS-OCTA scan pattern data were used to
find difference between IRMA and NVs. Patients
with any other retinal disorders, including history
of vitreoretinal surgery, glaucoma, uveitis and
presence of media opacities, such as severe vitreous
hemorrhage, cataract and corneal opacity and also
with previous history of Intravitreal injection of
anti-VEGF, steroids and laser were excluded.
Statistical analysis: Statistical analysis was done
using SPSS version 23.0. All continuous variables
were presented as mean with standard deviation.
The Categorical data is presented as frequency and
percentages. Chi square test was applied to see
the significance of OCTA for grading of DR and
qualitative features of IRMAs and NVs. A p-value
< 0.05 was considered to be statistically significant.

METHODS

Twenty-one patients were included in this study.
Out of which, 11 (52%) were male and 10 (48%)
were female. Mean age of the patients was 50.71
± 9.249 years with range of 37-65 years. Overall, 42

This cross-sectional observational study was
performed at ISRA Postgraduate Institute of
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Table-I: Clinical and OCTA diagnosis.
Clinical
Diagnosis
PDR
Severe
NPDR
Total

OCTA Diagnosis

Total

PDR

Severe NPDR

13

0

13

46.4%

0.0%

46.4%

2

13

15

7.1%

46.4%

53.6%

15

13

28

53.6%

46.4%

100.0%

Table-II: OCTA findings and Abnormal Vascular Lesions.
P-value

OCT abnormal
vascular Lesions
IRMA=1

0.001

*Chi-square test was applied to see the significance.
OCTA: Optical coherence tomography angiography,
PDR: Proliferative diabetic retinopathy, NPDR: Nonproliferative diabetic retinopathy.

NV=2
Total

Supra retinal flow

Total

NO

YES

36

0

36

64.3%

0.0%

64.3%

0

20

20

0.0%

35.7%

35.7%

36

20

56

64.3%

35.7%

100.0%

P-value

0.001

*Chi-square test was applied to see the significance,
OCT: Optical coherence tomography, IRMA: Intraretinal
microvascular abnormalities, NV: Neovascularization.

eyes (21 patients) were examined clinically, with
14 eyes having moderate NPDR, 15 had severe
NPDR and 13 eyes with changes consistent with
PDR. After clinical diagnosis, we included 28 eyes
in our study based on inclusion criteria. These 28
eyes went through SS-OCTA evaluation with 15
eyes showing PDR and 13 eyes with severe NPDR
changes. The OCTA and clinical diagnosis were
almost similar except in 2 eyes, which is critical with
P-value 0.001 (Table-I). We observed 56 irregular
abnormal looking vasculatures on enface OCTA

The DR remains asymptomatic until the pathology
is significantly advanced. It is therefore imperative to

Fig.1: Intra Retinal Microvascular Abnormalities.
a. Magnified 12mm×12mm en face OCTA showed IRMA,
b. Co-registered OCT with ﬂow overlay of OCTA data
conﬁrms intra retinal ﬂow below the ILM.

Fig.2: Retinal new vessels and
Intra retinal microvascular abnormalities.
a. Magniﬁed en face 12 mm ×12 mm OCTA of two retinal
lesions, yellow arrow showing new vessels (NV) and Red
arrow representing Intraretinal microvascular abnormalities (IRMAs), b. Flow overlay of OCTA conﬁrmed
suprarenal and intraretinal ﬂow.
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and co registered OCT with flow overlay of OCTA.
Out of these 56 lesions, 36 (64%) were IRMAs (Fig.1
and Table-II) found restrained under the ILM with
intra retinal flow. Twenty lesions (36%) were NVs
(Fig.2), Out of 20 lesions, 18 (90%) were in advanced
stage penetrating ILM and posterior hyaloid (Fig.3)
and 2 (2%) lesions were found only breaching ILM.
DISCUSSION
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Fig 3. New Vessels adjacent to areas of capillary loss.
a. Magnified 12mm×12mm en face OCTA showed
capillary loss, b. Co-registered OCT with flow overlay of
OCTA found advance NVs.

detect retinal changes at an early stage.10 Sometimes
IRMA may be difficult to find clinically, because
the appearance could be restrained, peripheral and
masked by the presence of retinal hemorrhages.
It is important therefore to distinguish between
IRMA and retinal NVs to determine diagnosis,
prognosis and treatment plan.10 In this study we
reviewed histopathologic definition of NVEs in
DR and demonstrated the use of SS OCT and
OCTA for the diagnosis of severity of DR. ETDRS
has highlighted the use of fundus fluorescein
angiography (FFA) in DR and has also described
its importance in the diagnosis of macular edema
and capillary Non perfusion.11 FFA is important
and useful test for assessing NVs, but leakage in
FFA alone may not be enough for differentiating
IRMAs from NVs, because leakage can also occur
in other vascular disorders. Furthermore, FFA is
an invasive test, time consuming, costly and has
potential for severe adverse effects varying from
mild nausea and vomiting to life threatening
complications.12 In 1997, OCT made revolutionized
change in ophthalmology especially in the field of
vitreo-retina. With this noninvasive technology we
can evaluate the disruption of ILM associated with
NVE.13-15 It still remains debatable that IRMAs are
precursors of NVE but it is eminent that the IRMAs
Pak J Med Sci
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increase the risk of PDR. Lee et al.16 described the
conversion from IRMA to NVE and suggested that
once there is a breach in ILM, the early NVs will
grow towards posterior hyaloid. In our study we
have observed multiple irregular vasculatures on
enface OCTA and co registered OCT with flow
overlay of OCTA, most of them are IRMAs, because
these lesions remain under ILM with intra retinal
flow and showing no breach in ILM. Ishibazawa
and colleague17 described NV on enface OCT
angiography, describing two distinct morphologic
features of the new vessels. Firstly, most new vessels
were irregular proliferation of ﬁne vessels, which
were deﬁned as exuberant vascular proliferation
(EVP). The second one was tiny vascular loops of
vessels. In our study we found 90% fine vessels and
most of them penetrating ILM and posterior hyloid
and can be explained as EVP. De Carlo et al.18 have
explained that retinal NVs appear near to retinal
non-perfusion areas and Arya and coworkers3 has
added that NVs develop in response to ischemia
and may be originating from IRMA and If these
vessels breach the ILM, they are deﬁned as retinal
NV with potential to proliferate. If we accept this
theory, our study has similarly showed the retinal
NVs and IRMAs present next to the areas of
capillary loss (Fig.3), making enface OCTA useful
in differentiating NPDR from PDR, and helping
in treatment planning with monitoring of the
disease intensity.19 Retinal NVs can be appreciated
on enface OCTA via observation of flow signal
above the ILM22. En face OCTA can identify early
retinal NVs20 and can recognize the origin and
morphological pattern of NVs in PDR. OCTA is
also able to detect subtle NVs, which are difficult to
differentiate from microanerysms on FFA.
Lee et al.16 has also described stages of NVs, with
stage I defined by the hyper reflective posterior
hyaloid layer appearing intact despite the presence
of the NVs through the break of the ILM not
extending into vitreous cavity, in Stage II, NVs are
defined by the growth along the posterior hyaloid.
In stage III, NVs appear to involve multiple
areas with breach of ILM and growth in different
planes. Our study has showed NVs growing along
the posterior hyaloid can be considered stage
II, according to the Lee’s classification. Pan and
colleague 20 have categorized three subtypes of
retinal NVs in PDR, based on OCTA images. Type-I
NVEs are tree shaped originating from the venous
circulation, Type-II are octopus shaped arising
from the capillary network, while Type-III have sea
fan shape with origin from IRMA. In our study we
Vol. 38 No. 1
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didn’t find the actual origin of NVs. Schaal et al.21
compared vascular abnormalities in DR with SSOCTA to color fundus photography and explained
variability between these modalities. Our study
has established that IRMA and retinal NVs can be
differentiated by using Wide ﬁeld OCTA. Wide
ﬁeld OCTA could be a reasonable alternative to
FFA in the assessment of IRMA and NVs, for either
DR screening or to monitor high risk DR eyes.
Limitations of the study: Limitations of this
study include, small number of cases and noncomparison with FFA frames. In future software
advancement may improve the utility of wide ﬁeld
OCTA for DR screening making grading of DR
easy in automated fashion.

8.

9.

10.

11.
12.

13.

CONCLUSION
The OCTA can potentially work as an excellent
alternative to FFA in the diagnosis of DR because
of its non-invasive and depth encoded technique.
It can therefore be used frequently to monitor the
progression of the disease and distinguish between
IRMAs and NVs.
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